NCT00084656 2022-04-14Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV MelanomaBristol-Myers SquibbPhase 2 Completed77 enrolled 13 charts
NCT00001685 2008-03-04Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and TyrosinaseNational Institutes of Health Clinical Center (CC)Phase 2 Completed114 enrolled